Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Sofie Lock Johansson, Helle Wulf-Johansson, Anders Schlosser, Ingrid L. Titlestad, Bruce Miller, Ruth Tal-Singer, Uffe Holmskov, Jørgen Vestbo, Grith Lykke Sørensen*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

86 Downloads (Pure)

Abstract

Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.

Original languageEnglish
Article number00021-2019
JournalERJ Open Research
Volume5
Issue number2
Number of pages4
ISSN2312-0541
DOIs
Publication statusPublished - 1. Apr 2019

Fingerprint

Dive into the research topics of 'Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients'. Together they form a unique fingerprint.

Cite this